Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
01/2007
01/23/2007US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases
01/23/2007US7166641 Diclofenac salt of lidocaine
01/23/2007US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases
01/23/2007US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid
01/23/2007US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1
01/23/2007US7166625 Method for treating fibrotic diseases and other indications
01/23/2007US7166623 Pain and inflammation
01/23/2007US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
01/23/2007US7166616 Substituted alkanoic acids
01/23/2007US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES
01/23/2007US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia
01/23/2007US7166598 Piperazine derivatives
01/23/2007US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives
01/23/2007US7166593 Glucocorticoid receptor modulators
01/23/2007US7166592 Antiinflammatory agents
01/23/2007US7166586 Sulfonamide lactam inhibitors of FXa and method
01/23/2007US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
01/23/2007US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement
01/23/2007US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
01/23/2007US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease
01/23/2007US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen
01/23/2007US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents
01/23/2007CA2329193C Process for synthesizing cox-2 inhibitors
01/23/2007CA2269946C Naphthyridine derivatives
01/23/2007CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof
01/18/2007WO2007008119A1 The use of ketoprofen in treating hemorrhoids
01/18/2007WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative
01/18/2007WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
01/18/2007WO2007007732A1 Agent for elevating adiponectin concentration
01/18/2007WO2007007524A1 Inhibitor of enzymatic activity of macrophage migration inhibitory factor
01/18/2007WO2007007162A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis
01/18/2007WO2007007160A2 Anti-madcam antibodies to treat fever
01/18/2007WO2006120010A3 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
01/18/2007WO2006014381A3 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies
01/18/2007WO2005097192A9 Active substance combination of a carbinol compound and an opioid
01/18/2007US20070015819 Novel compounds
01/18/2007US20070015775 Heterocyclic compounds
01/18/2007US20070015772 Nucleoside metabolism inhibitors
01/18/2007US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists
01/18/2007US20070015755 Novel compounds and compositions as protease inhibitors
01/18/2007US20070015257 Alpha-MSH related compounds and methods of use
01/18/2007US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal
01/18/2007US20070014861 Treatment of proctitis
01/18/2007US20070014860 Treatment of esophagitis
01/18/2007US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
01/18/2007US20070014816 such as a botulinum toxin; pain is not associated with a headache pain
01/18/2007US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization
01/18/2007DE3915617B4 Verwendung einer ein Cyclosporin enthaltenden Zusammensetzung zur topischen Applikation Use of a composition containing a cyclosporin for topical application
01/18/2007CA2614754A1 Pharmaceutical compositions comprising a tgf-beta superfamily member
01/18/2007CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
01/18/2007CA2614622A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis
01/18/2007CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
01/17/2007EP1743945A1 Screening method
01/17/2007EP1743944A1 Novel method of screening
01/17/2007EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function
01/17/2007EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen
01/17/2007EP1743657A2 Stabilisation of macrolides
01/17/2007EP1743655A1 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents
01/17/2007EP1743635A2 Gibberellins for the promotion of ulcer healing
01/17/2007EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives
01/17/2007EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
01/17/2007EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
01/17/2007EP1742922A1 Crystalline pyrazole derivative
01/17/2007EP1742916A1 Phenyl compounds and their use in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
01/17/2007EP1537110B1 Triazospiro compounds having nociceptin receptor affinity
01/17/2007EP1532148B1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity
01/17/2007EP1432445B1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex
01/17/2007EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
01/17/2007EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
01/17/2007EP1272160B1 Lipid-based drug delivery systems for topical application
01/17/2007EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
01/17/2007EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents
01/17/2007EP1223977B1 Modified plant viruses and methods of use thereof
01/17/2007EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
01/17/2007EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
01/17/2007CN1898243A Bicyclic heterocyclic p-38 kinase inhibitors
01/17/2007CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
01/17/2007CN1897976A Antagonists of the bradykinin b1 receptor
01/17/2007CN1897953A Anti-inflammatory agents
01/17/2007CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
01/17/2007CN1897929A Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
01/17/2007CN1896104A Fused protein for cell inhibitory factor and albumin
01/17/2007CN1896076A Tricyclic-type compound, and medicine having it as effective component
01/17/2007CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics
01/17/2007CN1895672A Multifunctional broad-spectrum obtundent of polyphyletic synergistic and its use
01/17/2007CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases
01/17/2007CN1895641A Medicinal preparation with blood-activating, anti-inflammatory and analgesic functions and its making method
01/17/2007CN1895637A Yuanqi ostealgia preparation and its making method
01/17/2007CN1895627A Ointment for treating tendon impediment and its preparation
01/17/2007CN1895624A Externally-applied medicinal liquid for treating rheumatalgia and wound and its preparation
01/17/2007CN1895577A Chinese-medicinal preparation for treating appendicitis
01/17/2007CN1895566A Medicinal composition for treating wind cold and rheumatic headache
01/17/2007CN1895560A Chinese medicine for treating rheumatosis and rheumatoid disease
01/17/2007CN1895559A Chinese-medicinal preparation for treating neck, shoulder, waist and skelagia
01/17/2007CN1895556A Preparation for treating rheumatosis
01/17/2007CN1895549A Soothe tendons and activating-blood anodyne plaster
01/17/2007CN1895517A Medicine for rheumatosis and its making method
01/17/2007CN1895505A Medicine for treating rheumatoid disease
01/17/2007CN1895497A Analgesic mixed with Chinese medicine
01/17/2007CN1895492A Medicine for treating difficult menstruation and its preparation